The presence and persistence of ERCC-1 positive circulating tumor cells predicts worse prognosis in primary ovarian cancer patients
Monday, May 23, 2016
Tweet
Transcript
Embed
Email
Bookmark
<<
<
>
>>
Tweet
Facebook
Email
Chapters
Introduction
Resistance to platinum-based chemotherapy
Background
Patients and Methods
Results
Capacity of Circulating Tumor Cells
Technologies in Liquid Biopsy
Bioinformatics Tool
Results
Plans for the Future
CTC’s in Screening?
Conclusion
No transcript for this webinar
More Information
Contact Us